giovedì 14 gennaio 2016

# s-pharma: about inflammation: aspirin vs reduced lethal prostate cancer

<< Among undiagnosed men who took regular aspirin, the risk of developing a lethal form of prostate cancer was reduced by 24 percent, and among those already diagnosed with the disease, regular aspirin use lowered their risk of dying from it by 39 percent >>

2016 Genitourinary Cancers Symposium, American Society of Clinical Oncology (ASCO). San Francisco from January 7-9, 2016


Nessun commento:

Posta un commento